Apolipoprotein E4 Isoform Mass (ApoE4)
Specific 299-amino-acid isoform of ApoE (Arg112, Arg158) with high affinity for LDL receptors and impaired amyloid-beta clearance.
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Analyte is within optimal non-reactive clinical parameters.
Undetectable in E3/E3 and E2 carriers
General reference distribution across unselected commercial populations.
Negative (non-carrier)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Alters domain interaction between N-terminal and C-terminal domains, causing rapid VLDL clearance but defective neuronal amyloid clearance.
Differential Diagnosis
Elevated Levels (ApoE4 High)
- •Heterozygous or homozygous ApoE4 allele carrier (heightened Alzheimer and ASCVD risk)
Low Levels (ApoE4 Low)
- •Non-carrier (ApoE3/E3 wild type or cardioprotective ApoE2)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for ApoE4
- Targeted organ system imaging or functional dynamic testing related to lipid clearance & neurobiology
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Apolipoprotein E4 Isoform Mass - The New England Journal of Medicine (2021). PMID: 33990124
- [2]ApoE4 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Apolipoprotein E4 Isoform Mass (ApoE4) into overall healthspan optimization.